Effect of childhood pneumococcal conjugate vaccination on invasive disease in older adults of 10 European countries: implications for adult vaccination

@inproceedings{Hanquet2019EffectOC,
  title={Effect of childhood pneumococcal conjugate vaccination on invasive disease in older adults of 10 European countries: implications for adult vaccination},
  author={Germaine Hanquet and Pavla Krizova and Palle Valentiner-Branth and Shamez N Ladhani and J. Pekka Nuorti and Agn{\'e}s Lepoutre and Jolita Mereckiene and Mirjam J. Knol and Brita Askeland Winje and Pilar Ciruela and Mar{\'i}a Ordob{\'a}s and Marcela Guevara and Eisin McDonald and Eva Morfeldt and Jana Koz{\'a}kov{\'a} and Hans-Christian Slotved and Norman K Fry and Hanna Rinta-Kokko and Emmanuelle Varon and Mary Corcoran and Arie van der Ende and Didrik Frimann Vestrheim and Carmen Mu{\~n}oz-Almagro and Pello Latasa and Jes{\'u}s Castilla and Andrew Charles Smith and Birgitta Henriques-Normark and Robert J. Whittaker and Lucia Pastore Celentano and Camelia Savulescu},
  booktitle={Thorax},
  year={2019}
}
BACKGROUND Pneumococcal conjugate vaccines (PCVs) have the potential to prevent pneumococcal disease through direct and indirect protection. This multicentre European study estimated the indirect effects of 5-year childhood PCV10 and/or PCV13 programmes on invasive pneumococcal disease (IPD) in older adults across 13 sites in 10 European countries, to support decision-making on pneumococcal vaccination policies. METHODS For each site we calculated IPD incidence rate ratios (IRR) in people… CONTINUE READING
12
Twitter Mentions

Citations

Publications citing this paper.
SHOWING 1-2 OF 2 CITATIONS

Effectiveness of 13-Valent Pneumococcal Conjugate Vaccine Against Invasive Disease Caused by Serotype 3 in Children: A Systematic Review and Meta-analysis of Observational Studies

Heather L. Sings, Philippe De Wals, +7 authors Luis Jodar
  • Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
  • 2019
VIEW 5 EXCERPTS
CITES BACKGROUND
HIGHLY INFLUENCED

References

Publications referenced by this paper.
SHOWING 1-10 OF 48 REFERENCES

comparison of the impact of pneumococcal conjugate vaccine 10 or pneumococcal conjugate vaccine 13 on invasive pneumococcal disease in equivalent populations

P naucler, galanis i, Morfeldt e
  • Clin Infect Dis
  • 2017

effectiveness of the 23 - valent pneumococcal polysaccharide vaccine ( PPV 23 ) against pneumococcal disease in the elderly : systematic review and meta - analysis

S Moberley, J Holden, DP tatham
  • PLoS One
  • 2017

the epidemiology of invasive pneumococcal disease in older adults in the post - PcV era . Has there been a herd effect ?

Houseman c, Hughes gJ, chapman Ke
  • Epidemiol Infect
  • 2017